文献速递类风湿关节炎

CCCTC结合因子:β-半乳糖苷α-2,6-唾液酸转移酶1的特异性转录因子,在类风湿关节炎中上调抗瓜氨酸化蛋白抗体的唾液酸化

CCCTC-binding factor: the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

研究筛选并验证了ST6GAL1的转录因子CTCF,发现RA患者血清中ST6GAL1和ACPA唾液酸化水平降低且与DAS28评分负相关,CTCF通过结合ST6GAL1的P2启动子增强ACPA唾液酸化、减弱ACPA炎症活性,并在B细胞特异性CTCF敲除小鼠的CIA模型中得到验证。

要点

  • RA患者血清ST6GAL1和ACPA唾液酸化水平降低,与DAS28评分负相关。
  • CTCF被筛选并验证为结合ST6GAL1 P2启动子的转录因子,增强ACPA唾液酸化。
  • B细胞特异性CTCF敲除小鼠CIA模型验证了CTCF对关节炎进展的影响。

核心结论

  • CCCTC结合因子是B细胞中β-半乳糖苷α-2,6-唾液酸转移酶1的特异性转录因子,在RA中上调ACPA的唾液酸化并减轻疾病进展。

研究设计与样本

  • 通过DNA pull-down和液相色谱-串联质谱筛选与ST6GAL1 P2启动子相互作用的转录因子,并用染色质免疫沉淀、双荧光素酶报告基因实验和电泳迁移率变动分析验证。
  • 在B细胞中敲低和过表达CTCF验证其对ST6GAL1表达和ACPA炎症效应的影响。
  • 构建B细胞特异性CTCF敲除小鼠的CIA模型探究CTCF对关节炎进展的影响。

主要发现

  • RA患者血清中ST6GAL1和ACPA唾液酸化水平降低,且与DAS28评分负相关。
  • CTCF被筛选并验证为与ST6GAL1 P2启动子相互作用的转录因子,增强ACPA唾液酸化,从而减弱ACPA的炎症活性。
  • 上述结果在B细胞特异性CTCF敲除小鼠构建的CIA模型中亦得到验证。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sialylation of the crystallizable fragment (Fc) of ACPAs, which is catalysed by β-galactoside α-2,6-sialyltransferase 1 (ST6GAL1) could attenuate inflammation of RA. In this study, we screened the transcription factor of ST6GAL1 and elucidated the mechanism of transcriptionally upregulating sialylation of ACPAs in B cells to explore its role in the progression of RA. METHODS: Transcription factors interacting with the P2 promoter of ST6GAL1 were screened by DNA pull-down and liquid chromatography with tandem mass spectrometry (LC-MS/MS), and verified by chromatin immunoprecipitation (ChIP), dual luciferase reporter assay and electrophoretic mobility shift assay (EMSA). The function of the CCCTC-binding factor (CTCF) on the expression of ST6GAL1 and the inflammatory effect of ACPAs were verified by knocking down and overexpressing CTCF in B cells. The CIA model was constructed from B cell-specific CTCF knockout mice to explore the effect of CTCF on arthritis progression. RESULTS: We observed that the levels of ST6GAL1 and ACPAs sialylation decreased in the serum of RA patients and were negatively correlated with DAS28 scores. Subsequently, CTCF was screened and verified as the transcription factor interacting with the P2 promoter of ST6GAL1, which enhances the sialylation of ACPAs, thus weakening the inflammatory activity of ACPAs. Furthermore, the above results were also verified in the CIA model constructed from B cell-specific CTCF knockout mice. CONCLUSION: CCCTC-binding factor is the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 in B cells that upregulates the sialylation of ACPAs in RA and attenuates the disease progression.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Zhao H, Wang H, Qin Y, et al. CCCTC-binding factor: the specific transcription factor of β-galactoside α-2,6-sialyltransferase 1 that upregulates the sialylation of anti-citrullinated protein antibodies in rheumatoid arthritis. Rheumatology (Oxford). 2024. PMID: 37326830. doi:10.1093/rheumatology/kead282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。